Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body’s nervous system.

A charity has urgently called for action to address the shortages of a crucial medication that enables individuals with ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system.

Barclays analyst Peter Lawson raised the firm’s price target on Exelixis (EXEL) to $29 from $25 and keeps an Equal Weight rating on the shares ...

Exelixis reported $515.2M in net product revenues in Q4'24, a 20% increase over net product revenues for Q4'23. See why I ...

Citi raised the firm’s price target on Exelixis (EXEL) to $45 from $38 and keeps a Buy rating on the shares following the Q4 report. The ...

Lantheus, a Massachusetts-based developer of radiopharmaceuticals, has agreed to acquire the radiopharma contract development and manufacturing organization (CDMO) Evergreen Theragnostics. Lantheus ...

World Cancer Day recognizes the millions of people affected by cancer each and every day. One cancer survivor in Saratoga ...

With the aim to add a “revenue generating CDMO arm,” Lantheus Holdings has bought New Jersey-based radiopharmaceutical ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...